Last10K.com

Urovant Sciences Ltd. (UROV) SEC Filing 8-K Material Event for the period ending Friday, March 1, 2019

Urovant Sciences Ltd.

HISTORY TOOLS
CIK: 1740547 Ticker: UROV

View differences made from one to another to evaluate Urovant Sciences Ltd.'s financial trajectory

Compare SEC Filings Year-over-Year (YoY) and Quarter-over-Quarter (QoQ)
Sample 10-K Year-over-Year (YoY) Comparison

Compare this 8-K Corporate News to its predecessor by reading our highlights to see what text and tables were  removed  ,   added    and   changed   by Urovant Sciences Ltd..

Continue

Assess how Urovant Sciences Ltd.'s management team is paid from their Annual Proxy

Definitive Proxy Statement (Form DEF 14A)
Screenshot example of actual Proxy Statement

Urovant Sciences Ltd.'s Definitive Proxy Statement (Form DEF 14A) filed after their 2019 10-K Annual Report includes:

  • Voting Procedures
  • Board Members
  • Executive Team
  • Salaries, Bonuses, Perks
  • Peers / Competitors

Continue

SEC Filing Tools
Ticker: UROV
CIK: 1740547
Form Type: 8-K Corporate News
Accession Number: 0001564590-19-006396
Submitted to the SEC: Wed Mar 06 2019 8:05:32 AM EST
Accepted by the SEC: Wed Mar 06 2019
Period: Friday, March 1, 2019
Industry: Pharmaceutical Preparations
Events:
  1. Event for Officers

External Resources:
Stock Quote
Social Media

Bookmark the Permalink:
https://last10k.com/sec-filings/urov/0001564590-19-006396.htm